FDA to allow COVID-19 treatments using blood from survivors

March 26th, 20200 SILVER SPRING, MD — The FDA has unlocked the use of convalescent plasma, derived from the blood of people who have recovered from COVID-19 and which may contain helpful antibodies, as an investigational treatment for patients with severe cases of the disease, according to a report from the website FierceBiotech. This technique has...